Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

64.86 -0.68 (-1.03%)
Streaming Delayed Price Updated: 12:55 PM EDT, Aug 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
59 60 Next >
Stock Of The Day: Historic Technical Analysis Lesson In CVS
'Market Memory' means that important price levels can stay intact for weeks, months, or even years. The chart of CVS proves this. 
Via Benzinga
CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst
New bipartisan legislation targets pharmacy benefit managers. 
Via Investor's Business Daily
Bipartisan Lawmakers Aim To Break Up Health Care Giants With New Legislation
Pharmacy-benefit managers (PBMs) have been scrutinized for their role in drug distribution for years. Now a bipartisan group of lawmakers is threatening to break up the companies behind these so-called... 
Via Benzinga
Why UnitedHealth Group Stock Was Falling Today
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
What the Options Market Tells Us About CVS Health
 
Via Benzinga
Key Takeaways From CVS Health Analyst Ratings
 
Via Benzinga
Is CVS Health Stock a Buy?
Via The Motley Fool
CVS Health's Options: A Look at What the Big Money is Thinking
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
What’s Behind These 3 Recent Analyst Stock Upgrades?
Three recent analyst ratings go beyond the consensus, making them a much more significant move for Wall Street analysts to consider. 
Via MarketBeat
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 7
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 2-6, 2024. 
Via Talk Markets
Topics Stocks / Equities
Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January
Blue Shield of California launches its Pharmacy Care Reimagined Initiative with Amazon Pharmacy and Abarca in January, aiming to save $500 million annually in drug costs. 
Via Benzinga
(CVS) - Analyzing CVS Health's Short Interest
 
Via Benzinga
Is CVS Health Stock an Underrated Buy?
Via The Motley Fool
CVS Health Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
Analyst Expectations For CVS Health's Future
 
Via Benzinga
UnitedHealthcare Faces Scrutiny Amid CEO's Tragic Death, Industry Criticism
UnitedHealthcare's claim denial practices are under scrutiny following the murder of CEO Brian Thompson, with criticism over its profit-driven approach to care. 
Via Benzinga
13 Healthcare Sector Stocks With Healthy Valuation
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty... 
Via Talk Markets
Topics Stocks Stocks / Equities
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity. 
Via Investor's Business Daily
This Citigroup Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
3 Key Analyst Upgrades: Why These Stocks Are Getting a Boost
Retail investors have a chance to break down the reasons behind the latest analyst upgrades and why they're being made in these three stocks. 
Via MarketBeat
Topics Economy
Billionaire Israel Englander Bought This High-Yield Dividend Stock Hand Over Fist in Q3. Should You Buy It Too?
Via The Motley Fool
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI
Wedbush Securities has issued an endorsement of the artificial intelligence software sector, with Managing Director Dan Ives predicting that 2025 will be a pivotal year for AI implementation across the... 
Via Benzinga
Topics Artificial Intelligence
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
 
Via Benzinga
Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
As President-elect Donald Trump prepares to return to the White House, renowned economist Mohamed El-Erian is cautioning against media oversimplification of the incoming administration's proposed... 
Via Benzinga
Topics Government World Trade
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing. 
Via Benzinga
1 Great Reason to Buy Realty Income and Hold It Forever
Via The Motley Fool
CVS Health Stock Is Moving Higher Monday: What's Going On?
CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
59 60 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.